Cleveland Clinic Lerner Research Institute Logo
Cleveland Clinic Lerner Research Institute Logo
  • About
  • Science
    • Laboratories
    • Office of Research Development
    • Clinical & Translational Research
      Participating in Research
    • Departments
      Biomedical Engineering Cancer Biology Cardiovascular & Metabolic Sciences Florida Research & Innovation Center Genomic Medicine Immunotherapy & Precision Immuno-Oncology
      Infection Biology Inflammation & Immunity Neurosciences Ophthalmic Research Quantitative Health Sciences Translational Hematology & Oncology Research
    • Centers & Programs
      Advanced Musculoskeletal Imaging Angiogenesis Center Cardiovascular Diagnostics & Prevention Computational Life Sciences Consortium for Pain Genitourinary Malignancies Research Genome Center
      Microbiome & Human Health Musculoskeletal Research Northern Ohio Alcohol Center Pathogen & Human Health Research Populations Health Research Quantitative Metabolic Research Therapeutics Discovery
  • Core Services
    • Ohio
      3D Printing Bioimage AnalysisBioRobotics & Mechanical Testing Cell Culture Cleveland Clinic BioRepository Computational Oncology Platform Computing Services Discovery Lab Electron Microscopy Electronics Engineering
      Flow CytometryGenomic Medicine Institute Biorepository Genomics Glassware Histology Hybridoma Immunohistochemistry Immunomonitoring Lab Instrument Refurbishing & Repair Laboratory Diagnostic
      Lerner Research Institute BioRepository Light MicroscopyMechanical Prototyping Microbial Culturing & Engineering Microbial Sequencing & Analytics Resources Media Preparation Molecular Biotechnology Nitinol Polymer Proteomics & Metabolomics SomaScan & Biomarker Therapeutics Discovery
    • Florida
      Bioinformatics
      Flow Cytometry
      Imaging
  • Education & Training
    • Graduate Programs Molecular Medicine PhD Program Postdoctoral Program
      Global Research Education Research Intensive Summer Experience (RISE) Undergraduate & High School Programs
  • News
  • Careers
    • Faculty Positions Research Associate & Project Staff Postdoctoral Positions Technical & Administrative Engagement & Belonging
  • Donate
  • Contact
  • About
  • Science
    • Scientific Programs
    • Laboratories
    • Office of Research Development
    • Clinical & Translational Research
      Participating in Research
    • Departments
      Biomedical Engineering Cancer Biology Cardiovascular & Metabolic Sciences Florida Research & Innovation Center Genomic Medicine Immunotherapy & Precision Immuno-Oncology
      Infection Biology Inflammation & Immunity Neurosciences Ophthalmic Research Quantitative Health Sciences Translational Hematology & Oncology Research
    • Centers & Programs
      Advanced Musculoskeletal Imaging Angiogenesis Center Cardiovascular Diagnostics & Prevention Computational Life Sciences Consortium for Pain Genitourinary Malignancies Research Genome Center
      Microbiome & Human Health Musculoskeletal Research Northern Ohio Alcohol Center Pathogen & Human Health Research Populations Health Research Quantitative Metabolic Research Therapeutics Discovery
  • Core Services
    • All Cores
    • Ohio
      3D Printing Bioimage Analysis BioRobotics & Mechanical Testing Cell Culture Cleveland Clinic BioRepository Computational Oncology Platform Computing Services Discovery Lab Electron Microscopy Electronics Engineering >
      Flow CytometryGenomic Medicine Institute BiorepositoryGenomics Glassware Histology Hybridoma Immunohistochemistry Immunomonitoring Lab Instrument Refurbishing & Repair Laboratory Diagnostic
      Lerner Research Institute BioRepository Light MicroscopyMechanical Prototyping Microbial Culturing & Engineering Microbial Sequencing & Analytics Resources Media Preparation Molecular Biotechnology Nitinol Polymer Proteomics & Metabolomics SomaScan & Biomarker Therapeutics Discovery
    • Florida
      Bioinformatics
      Flow Cytometry
      Imaging
  • Education & Training
    • Research Education & Training Center
    • Graduate Programs Molecular Medicine PhD Program Postdoctoral Program
      Global Research Education Research Intensive Summer Experience (RISE) Undergraduate & High School Programs
  • News
  • Careers
    • Faculty Positions Research Associate & Project Staff Postdoctoral Positions Technical & AdministrativeEngagement & Belonging
  • Donate
  • Contact
  • Search

Research News

❮News Evolutionary model for antibiotic resistance reveals dose timing critical to care

06/11/2025

Evolutionary model for antibiotic resistance reveals dose timing critical to care

Using a form of evolutionary modeling called "seascape models," Cleveland Clinic researchers can predict what happens if you miss a dose of antibiotics.

a weekly pill box

Cleveland Clinic researchers are improving the way we use evolutionary modeling to understand drug resistance. The study, published in Science Advances, uses a new type of evolutionary model called a “​fitness seascape​” to incorporate a patient’s dosage schedule into ​models​ that predict whether an infection will develop antibiotic resistance, and has found that inconsistent timing and missing early doses can lead to treatment failure. 

Dr. Scott’s team, including study first author Eshan King, an MD/PhD student​ at Case Western Reserve University School of Medicine​, is refining ​models​ that determine recommended antibiotic doses by incorporating​ bacterial​ evolutionary ​dynamics​. 

“The world is reaching a crisis point with the rise of ‘superbugs,’ or antibiotic-resistant bacterial infections,” says the study’s senior author Jacob Scott, MD, DPhil. “We’ve already seen from MRSA what can happen if a bacterium becomes antibiotic-resistant. We need to address the problem before it impacts our ability to use antibiotics in more routine aspects of medical care, like surgery or childbirth.” 

Building seascape models to empower evolutionary modeling 

Doctors typically use guidelines from drug companies to decide medication dosages for their patients. These guidelines rely on equations ​that describe how antibiotics are absorbed in the body ​to calculate the smallest effective dose that treats the disease, without letting the diseased area evolve a drug-resistant mutation. Under Dr. Scott’s mentorship, King has been ​expanding​ some of these ​models​ to better reflect how changes in a medication’s concentration in our bloodstream affect treatment resistance. 

"Many ​models​ assume the environment around a diseased area doesn't change, but the environment of an infection is our own bodies. That’s never truly constant,” King says.​ “Our manuscript builds on previous work to account for changes in drug concentration over time within our bodies.”​ 

Seascape models are equations that include variables that change over time​ or space​, like drug concentration. This allows investigators like King to study new aspects of antibiotic resistance, like how the timing between doses influences medication levels in diseased areas. King used seascape modeling to simulate the outcomes of hundreds of virtual patients being treated for bacterial infections with IV and oral antibiotics. 

“Other models have drug concentration as an input, and evolutionary outcome (treatment resistance) as an output. Instead of testing different drug concentrations in separate patients, our model lets us kind of turn a dial to change concentrations in one patient over time​ to better reflect how our bodies process drug doses​,” Dr. Scott explains. 

Medication timing influences antibiotic resistance 

Before this study, missing a dose or stopping antibiotics treatment early was emphasized as a main contributor to treatment resistance. King was surprised to find simulated patients who developed treatment resistance were taking roughly the same amount of medication as those who successfully eliminated their infection.  

Instead of the presence or absence of medication at all, it was the timing of the medication doses that differed between these two groups. The team found that missing or being late with early doses played a bigger role in developing antibiotic resistance than missing or being late with a later dose. 

The team tested these findings in the lab by treating bacteria with different antibiotic ​regimens. ​​​The bacteria that received all the recommended dose at the recommended time were unlikely to develop treatment resistance. ​​​Similarly, bacteria that were appropriately received the early doses but missed later doses did not develop resistance. In contrast, the bacteria that missed early doses but were appropriately treated later evolved treatment resistance, highlighting a potential mechanism of treatment failure in a patient. ​ 

"These results are shaping how I will counsel my patients,” King says. “I will emphasize that they really need to be on top of taking their antibiotics at the recommended time intervals, especially at the beginning. If they take the first dose and then miss the second dose and then take the third dose, that might not work out so well. ​There is a​ higher likelihood that this treatment will fail, and ​we will​​ ​have to try something else." 

Featured Experts
Jacob Scott Headshot
Jacob
Scott, MD, DPhil
News Category
Related News
Immune protein modification blocks viral replication, heart inflammationDr. Michaela Gack Receives Prestigious NIH Director’s Pioneer AwardNew Study From Cleveland Clinic Pathogens Researchers Points to Novel Drug Target for Treating COVID-19

Research areas

Translational Hematology & Oncology Research

Want To Support Ground-Breaking Research at Cleveland Clinic?

Discover how you can help Cleveland Clinic save lives and continue to lead the transformation of healthcare.

Give to Cleveland Clinic

Subscribe to get the latest research news in your inbox.

About Lerner

About Us Careers Contact Us Donate People Directory

Science

Clinical & Translational Research Core Services Departments, Centers & Programs Laboratories Research News

Education & Training

Graduate Programs Global Research Education Molecular Medicine PhD Program Postdoctoral Program RISE Program Undergraduate & High School Programs

Site Information & Policies

Privacy Policy Search Site Site Map Social Media Policy

9500 Euclid Avenue, Cleveland, Ohio 44195 | © 2025 Lerner Research Institute